Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Clinical trial NCT06912633 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06912633
- Sponsor
- jCyte, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.